ABIN406711
antibody from antibodies-online
Targeting: LRP1
A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN406711 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) (Middle Region) antibody
- Antibody type
- Polyclonal
- Antigen
- The immunogen for anti-LRP1 antibody: synthetic peptide directed towards the middle region of human LRP1
- Description
- Affinity Purified
- Reactivity
- Human
- Host
- Rabbit
- Antigen sequence
ATYLSGAQVSTITPTSTRQTTAMDFSYANETVCWV
HVGDS AAQTQLKCAR- Epitope
- Middle Region
- Vial size
- 50 μg
- Concentration
- 1mg/mL
- Storage
- -20°C
- Handling
- Avoid repeated freeze-thaw cycles.
Submitted references Is the atherosclerotic phenotype of preeclamptic placentas due to altered lipoprotein concentrations and placental lipoprotein receptors? Role of a small-for-gestational-age phenotype.
Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice.
Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.
Hentschke MR, Poli-de-Figueiredo CE, da Costa BE, Kurlak LO, Williams PJ, Mistry HD
Journal of lipid research 2013 Oct;54(10):2658-64
Journal of lipid research 2013 Oct;54(10):2658-64
Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice.
Gu H, Wei X, Monnot AD, Fontanilla CV, Behl M, Farlow MR, Zheng W, Du Y
Neuroscience letters 2011 Feb 18;490(1):16-20
Neuroscience letters 2011 Feb 18;490(1):16-20
Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.
Behl M, Zhang Y, Monnot AD, Jiang W, Zheng W
Toxicology and applied pharmacology 2009 Oct 15;240(2):245-54
Toxicology and applied pharmacology 2009 Oct 15;240(2):245-54
No comments: Submit comment
No validations: Submit validation data